Vous n'êtes pas connecté
- English
- Français
- عربي
- Español
- Deutsch
- Português
- русский язык
- Català
- Italiano
- Nederlands, Vlaams
- Norsk
- فارسی
- বাংলা
- اردو
- Azərbaycan dili
- Bahasa Indonesia
- Հայերեն
- Ελληνικά
- Bosanski jezik
- українська мова
- Íslenska
- Türkmen, Түркмен
- Türkçe
- Shqip
- Eesti keel
- magyar
- Қазақ тілі
- Kalaallisut ; kalaallit oqaasii
- Lietuvių kalba
- Latviešu valoda
- македонски јазик
- Монгол
- Bahasa Melayu ; بهاس ملايو
- ဗမာစာ
- Slovenščina
- тоҷикӣ ; toğikī ; تاجیکی
- ไทย
- O'zbek ; Ўзбек ; أۇزبېك
- Tiếng Việt
- ភាសាខ្មែរ
- རྫོང་ཁ
- Soomaaliga ; af Soomaali
Maroc - PULSE.COM.GH - A la Une - 26/Feb 10:53
BBC opioid exposé: FDA suspends Aveo Pharmaceuticals’ GMP certificate
BBC opioid exposé: FDA suspends Aveo Pharmaceuticals’ GMP certificate
Articles similaires
NAFDAC Blacklists Indian Firm For Importing Hard Drugs
The National Agency for Food and Drug Administration and Control has blacklisted an Indian firm, Aveo Pharmaceuticals Pvt Limited, over alleged...
NAFDAC blacklists Indian firm for importing hard drugs
The National Agency for Food and Drug Administration and Control (NAFDAC) has blacklisted the Indian company, Aveo Pharmaceuticals Pvt Limited, for...
NAFDAC blacklists Indian form for importing hard drugs
The National Agency for Food and Drug Administration and Control (NAFDAC) has blacklisted the Indian company, Aveo Pharmaceuticals Pvt Limited, for...
NAFDAC, Sanctions Indian Firm Over Production, Importation Of Illicit Drugs
The National Agency for Food and Drug Administration and Control, NAFDAC, has blacklisted an Indian firm, Aveo Pharmaceuticals Pvt Limited,...
Spark Biomedical Receives Health Canada’s Medical Device License for Sparrow Ascent Opioid Withdrawal Treatment
New Health Canada Approval Allows Spark Biomedical to Offer Drug-Free Opioid Withdrawal Relief Across Canada. Dallas, TX, March 05, 2025 (GLOBE...
FDA Approves Encelto (revakinagene taroretcel-lwey) for the Treatment of Macular Telangiectasia Type 2 (MacTel)
CUMBERLAND, R.I.--(BUSINESS WIRE)--Neurotech Pharmaceuticals, Inc., a private biotech company focused on developing transformative therapies for...
NAFDAC Blacklists Indian Pharmaceutical Firm Over Dangerous Addictive Pills
NAFDAC’s Director-General, Prof. Mojisola Adeyeye, made the announcement at a press briefing in Abuja on Friday, revealing that the company operates...
ARS Pharmaceuticals Announces FDA Approval of neffy 1 mg (epinephrine nasal spray) for Type I Allergic Reactions in Pediatric Patients
SAN DIEGO, March 05, 2025 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk...
Les derniers communiqués
-
Aucun élément